AMANDA PERRY: Open Payments
NPI 1265116610 · SAINT MARYS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 85 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $799 · 2025 $1,362
Food & beverage: $1,362
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $527 |
| Neurocrine BioSciences, Inc. | 6 | $110 |
| Biogen, Inc. | 5 | $93 |
| EMD Serono, Inc. | 4 | $76 |
| Alexion Pharmaceuticals, Inc. | 3 | $76 |
| Lilly USA, LLC | 3 | $50 |
| PFIZER INC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| SK Life Science, Inc. | 3 | $47 |
| Eisai Inc. | 2 | $35 |
Products named: QULIPTA, UBRELVY, INGREZZA, ULTOMIRIS, TYSABRI, AMYVID, NURTEC ODT, WAINUA.
Industry payments across OH — which companies pay providers there.
